Technical Standards for Neuroendocrine Cancer Surgery

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the requirements of the American Board of Surgery’s Continuous Certification program. 

Diplomates of the American Board of Surgery

By attending an ACS-accredited activity, you may choose to participate in the automatic transfer of your CME credits to the ABS via the ACCME.  If you are a physician and Diplomate of the American Board of Surgery (ABS). This is a free offering. 

Opt in to Automatically Send your CME Data to the ABS

The direct automatic transfer applies to all learners who have an ACS profile, are Diplomates of the ABS, and have provided their ABS ID and date of birth in the ACS MyCME Portal on the Board Certification page. 
 
Step-by-Step Instructions to Access MyCME and Opt in to Transmit Your CME Data

1. Log in to your MyCME Portal
2. Select the Board Certification tab
3. Enter the American Board of Surgery
4. Enter your ABS ID
5. Enter your Day and Month of birth
6. Next go to the Send CME Data tab
7. Toggle to Opt In (green) “Yes! I choose to opt in and permit the ACS to automatically transfer all my ACS-accredited CME data to my chosen specialty board earned March 1, 2021, and forward.”  

Please note if you have successfully transmitted your ACS-accredited CME credits to the ABS via ACCME, then you can skip steps 2-6, and go directly to the Send CME Data tab, and Toggle to Opt In (green). 

Once you have opted to automatically transfer your CME credits to the ABS, please allow 24 hours after transferring claiming your CME credits before you log into your ABS account to confirm the credits are in your ABS CME Repository. 

You may opt out at any time.

For more information or to request assistance, contact mycme@facs.org. 

This forum will discuss evidence-based operative standards for the performance of neuroendocrine surgery as outlined in the Cancer Surgery Standards Textbook, Volume 3. This will include a review of technical standards and the rationale supporting these recommendations. At the completion of the activity, participants should be able to:

• Recognize the key operative standards for the performance of surgery for small bowel and pancreatic neuroendocrine tumors with locoregional lymphadenectomy,  
• Understand evidence for hepatic cytoreduction in metastatic small bowel neuroendocrine tumors 
• Understand evidence-based rationale for these standards. 
• Describe technical aspects of the operative standards.  
• Gain insight into current controversies and opportunities for ongoing improvement.

In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf of all other authors/contributors, if applicable.

Ineligible Company: The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.

• Financial Relationships: Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
• Conflict of Interest: Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.

Seth Concors, MD, FACS – Nothing to disclose

Callisia Clark, MD, MS, FACS, FSSO – Nothing to disclose

Alexandra Gangi, MD, FACS – Nothing to disclose

James Howe, MD, FACS – Disclosed relationships with Abbot Labs, Pfizer, Neuroendocrine Cancer Awareness Network

Jessica Maxwell, MD, FACS – Nothing to disclose

Daniel Halperin, MD, FACS – Disclosed relationships with Exelixis, AbbVie, Harpoon Therapeutics, ITM, Novartis, Crinetics, Amryt, Camurus, Alphamedix, Chimeric Therapeutics, Sanofi

Timothy Vreeland, MD, FACS – Nothing to disclose

Tracy Wang, MD, FACS – Disclosed relationship with Intuitive Surgical

Amanda Francescatti, MS – Nothing to disclose

Bell Pastore – Nothing to disclose